ProtaGene is excited to announce our expanded molecular bioanalytical solutions capacity and capabilities – explicitly tailored for gene therapy developers. Our molecular bioanalytical solutions are designed to enable preclinical assessment of safety risks and monitoring of gene therapies in the clinic.
Our scientific expertise, experience across a wide range of therapeutics and regions, multi-continent foundation, and commitment to quality provide complete analytic solutions for protein biologics and cell and gene therapeutics throughout products’ development and regulatory life cycles—from discovery to market.
Enabled by state-of-the-art technology, ProtaGene offers an extensive range of analytical capabilities to support your biotherapeutic or gene & cell therapy projects.
Whether you are looking to learn more about our platforms or get a project started, contact our team today to discover how ProtaGene can support your development programs.Contact Us